Page 15
However, their use in prevention of postoperative cystoid macular edema is central in their prescribing frequency. – “Alarmingly, topical NSAIDs may be used by eyecare practitioners for extended periods of time without a clear diagnosis or indication.” – “Corneal complications of topical NSAIDs include superficial punctate keratopathy (punctate epithelial erosions), corneal infiltrates, and epithelial defects; the most severe of all is corneal melt.” – “An intriguing aspect of such melt is the apparent requirement for a compromised cornea for it to occur.” It appears that compromised epithelial cells respond differently to NSAIDs than healthy ones. – “Some ocular surface diseases such as dry eye are considered relative—and for most experts—absolute contraindications to the use of ocular NSAIDs.” • Festoons. These are fluid-filled, “squishy” pockets gravitationally exacerbated by age-related laxity of the upper facial muscles. They can also accompany inflammatory dermatologic diseases; most relevant to us, herpes zoster ophthalmicus. These non-tender festoons look bad but carry no pathological relevance. The treatment is patient reassurance, or if he/she desires, a referral for facial plastic surgery. • Medicines that can cause dysgeusia: prednisolone acetate, lifitegrast, topical carbonic anhydrase inhibitors and azelastine. 1. Stuart A. Drug Toxicity to the Retina and Optic Nerve: Are You Missing It? EyeNet Magazine. September 2019. Available at: https:// www.aao.org/eyenet/article/drug-toxicity-to-the-retina-and-opticnerve?september-2019 (last accessed April 14, 2020). 2. Sator L, Horner A, Studnicka M, et al. Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD analysis. Chest. 2019 Aug;156(2):277-88. 3. Mullee A, Romaguera D, Pearson-Stuttard J, et al. Association between soft drink consumption and mortality in 10 European countries. JAMA Intern Med. 2019;179(11):1479-90. 4. Thompson V. Examining presbyopia treatments. Eye World. December 2019. Availablee at: https://www.eyeworld.org/examiningpresbyopia-treatments (last accessed April 14, 2020). 5. Sathiamoorthi S, Frank RD, Mohney BG. Spontaneous resolution and timing of intervention in congenital nasolacrimal duct obstruction. JAMA Ophthalmol. 2018; Nov 1;136(11):1281-6. 6. Hwang AD, Tuccar-Burak M, Peli E. Comparison of pedestrian detection with and without yellow-lens glasses during simulated night driving with and without headlight glare. JAMA Ophthalmol. 2019; Aug 1. 7. Keen M, Thompson M. Treatment of acute conjunctivitis in the united states and evidence of antibiotic overuse: isolated issue or a systematic problem? 2017; Aug; 124(8):1096-8. 8. Migraines & FL-41 Tinted Lenses. University of Utah Health/Moran Eye Center. Available at: https://healthcare.utah.edu/moran/optometry/fl41-lenses.php (last accessed April 14, 2020). 9. Wallace DV, Dykewicz, Oppenheimer J, et al. pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 Joint Task Force on Practice Parameters.